Publication | Open Access
TGF‐β1 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation
64
Citations
95
References
2022
Year
Our results show that TGF-β1 is an essential regulator of ECM deposition in secondary lymphedema and that inhibition of this response is a promising means of treating lymphedema.
| Year | Citations | |
|---|---|---|
Page 1
Page 1